Compare CORT & REXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | REXR |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 8.4B |
| IPO Year | 2001 | 2013 |
| Metric | CORT | REXR |
|---|---|---|
| Price | $111.91 | $36.27 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 10 |
| Target Price | ★ $96.50 | $41.00 |
| AVG Volume (30 Days) | 1.3M | ★ 3.0M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 4.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | $761,407,000.00 | ★ $1,003,133,000.00 |
| Revenue This Year | $26.08 | $0.09 |
| Revenue Next Year | $26.98 | $2.99 |
| P/E Ratio | $1,267.14 | ★ $43.28 |
| Revenue Growth | ★ 12.79 | 7.13 |
| 52 Week Low | $28.66 | $32.14 |
| 52 Week High | $122.21 | $44.38 |
| Indicator | CORT | REXR |
|---|---|---|
| Relative Strength Index (RSI) | 65.59 | 48.42 |
| Support Level | $76.41 | $36.32 |
| Resistance Level | $122.21 | $37.73 |
| Average True Range (ATR) | 5.21 | 0.92 |
| MACD | 0.55 | -0.27 |
| Stochastic Oscillator | 72.40 | 15.76 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Rexford Industrial Realty Inc is a real estate investment trust focused on owning, operating and acquiring industrial properties in Southern California infill markets. Its goal is to generate attractive risk-adjusted returns for the stockholders by providing superior access to industrial property investments and mortgage debt investments secured by industrial property in high-barrier Southern California infill markets. The company generates revenue from rental income derived from properties in its portfolio.